The cells were cultured in Dulbeccos Modified Eagles Medium/Nutrient Mixture F-12 (DMEM/F12 = 1:1) supplemented with 5% (v/v) fetal bovine serum, 1 mM pyruvate, 50 g/mL penicillin, 50 g/mL streptomycin, 10 g/mL insulin, 5.5 g/mL transferrin, 5 ng/mL sodium selenite, and 5 ng/mL epidermal growth factor and maintained at 37 C in a sterile, humidified atmosphere of 5% CO 2
Potential Benefits of LL-37 Peptide Therapy LL-37 peptide therapy is increasingly explored for its potential role in: Immune regulation Skin barrier support Antimicrobial defense Tissue healing Potential benefits may include: Reduced inflammatory burden Improved skin recovery Enhanced barrier integrity Support for microbial balance Because rosacea involves complex immune pathways, physician supervision is important when considering immune-modulating peptides
Aryl sulfonamide inhibitors of insulin-regulated aminopeptidase enhance spine density in primary hippocampal neuron cultures
Every batch is third-party tested for purity, potency, and safety giving you confidence with every dose
Severe chronic conditions may need 12+ weeks plus ongoing maintenance
